REVIEW
Published on 10 Jun 2025
Evaluation of three mechanisms of action (SGLT2 inhibitors, GLP-1 receptor agonists, and sulfonylureas) in treating type 2 diabetes with heart failure: a systematic review and network meta-analysis of RCTs
doi 10.3389/fendo.2025.1562815
- 475 views